This is a key concept in patient safety that was introduced by the Institute for Safe Medication Practices (ISMP) to identify medicines on which to target safety efforts and improvement interventions.4 On the other hand, pediatric patients constitute a particularly vulnerable group on account of several factors that increase both the frequency of medication errors and the severity of the associated adverse events.5,6 Therefore, for this patient group, it is particularly crucial to implement effective measures to prevent errors in the use of these medications and to minimize the severe or fatal consequences that may result.1 In Spain, the Ministry of Health, in the framework of the Strategy for Patient Safety of the National Health System,7 has promoted the adoption of safety practices for high-risk medications and the development of specific interventions to reduce the incidence of medication errors in pediatric patients
The solution for supporting APOE4 is following a healthy lifestyle
Injectable hyaluronan hydrogels with peptide-binding dendrimers modulate the controlled release of BMP-2 and TGF-1
La suplementacin con estas vitaminas puede ayudar a optimizar la utilizacin de la L-Carnitina en el cuerpo
Rusilowicz-Jones, E
After completing her PhD at the University of Adelaide and receiving Dean's Commendation for Doctoral Research Excellence, Hannah secured an NHMRC CJ Martin Biomedical training fellowship allowing her to relocate to the University of Groningen, the Netherlands